[ET Net News Agency, 8 December 2023] CSTONE PHARMA-B (02616) rose 10.7% to HK$2.27,
breaking above the 100-D SMA of HK$2.161.
It hits an intra-day high of HK$2.3, and an intra-day low of HK$2, hitting an 1-month
low. The total shares traded was 4.59 million, with a value of HK$9.72m. The active
buy/sell ratio is 59:41, with net buying turnover of HK$1.67m. CHINA INV INFO accounts for
greatest net responsive buying turnover of HK$1.59m, with volume weighted average price of
HK$2.132. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover
of HK$830,728, with volume weighted average price of HK$2.119.
Basic Information
=================
---------------------------------
Nominal 2.270 % Chg +10.73%
High 2.300 Low 2.000
Shares Tr 4.59m Turnover 9.72m
10-D SMA 2.205 %H.V 57.994
20-D SMA 2.302 VWAP 2.120
50-D SMA 2.102 RSI14 52.404
---------------------------------
Status: Breaking above the 100-D SMA, hitting an 1-month low, active buy/sell ratio is
59:41, with net buying turnover of HK$1.67m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 2.27 +10.73
HUTCHMED (00013) 29.85 +1.88
GENSCRIPT BIO (01548) 20.30 +0.25
INNOVENT BIO (01801) 39.45 -2.11
EVEREST MED-B (01952) 19.78 +0.61
KEYMED BIO-B (02162) 50.75 -5.76
WUXI BIO (02269) 29.30 -2.17
BEIGENE (06160) 107.00 -1.74
ZAI LAB (09688) 21.00 -1.18
AKESO (09926) 43.10 -2.05
-----------------------------------------------
(ed)